JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 1988; 12:166-174
© 1988 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trappe, H.
Right arrow Articles by Wellens, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trappe, H.
Right arrow Articles by Wellens, H.

Prognosis of patients with ventricular tachycardia and ventricular fibrillation: role of the underlying etiology

HJ Trappe, P Brugada, M Talajic, P Della Bella, R Lezaun, R Mulleneers, and HJ Wellens

Department of Cardiology, Academic Hospital Maastricht, The Netherlands.

The prognosis of 149 patients with ventricular tachycardia (n = 108) or ventricular fibrillation (n = 41) was analyzed to assess the importance of the underlying etiology of the arrhythmia. Seventy-three patients (Group I) had a previous myocardial infarction and documented late sustained monomorphic ventricular tachycardia. Thirty-five (Group II) also had a previous myocardial infarction but had late ventricular fibrillation. There were 41 patients (Group III) without coronary artery disease: 9 patients with right ventricular dysplasia, 26 with idiopathic sustained ventricular tachycardia and 6 with idiopathic ventricular fibrillation. The mean follow-up period for all patients was 22 to 57 months. The total mortality rate in Group I (16%) and Group II (34%) and the arrhythmic mortality rate in Group I (5%) and Group II (11%) were significantly higher than the rates in Group III. In the latter group the total mortality rate was 4% for those with idiopathic ventricular tachycardia and 11% for those with right ventricular dysplasia, and there were no deaths due to arrhythmia (p less than 0.05). Left ventricular ejection fraction was significantly lower and left ventricular end-diastolic pressure was significantly higher in Group I and Group II than in Group III. There were nonfatal recurrences of ventricular tachycardia in 33 to 56% of patients, and the number of these episodes did not differ significantly in those with and without coronary artery disease.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
 Cardiovasc ResHome page
N. Sotoodehnia, A. Zivin, G. H Bardy, and D. S Siscovick
Reducing mortality from sudden cardiac death in the community: lessons from epidemiology and clinical applications research
Cardiovasc Res, May 1, 2001; 50(2): 197 - 209.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
S. S. Chugh, K. L. Kelly, and J. L. Titus
Sudden Cardiac Death With Apparently Normal Heart
Circulation, August 8, 2000; 102(6): 649 - 654.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
V. Kuhlkamp, C. Mewis, J. Mermi, R. F. Bosch, and L. Seipel
Suppression of sustained ventricular tachyarrhythmias: a comparison of d,l-sotalol with no antiarrhythmic drug treatment
J. Am. Coll. Cardiol., January 1, 1999; 33(1): 46 - 52.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
Survivors of Out-of-Hospital Cardiac Arrest With Apparently Normal Heart: Need for Definition and Standardized Clinical Evaluation
Circulation, January 7, 1997; 95(1): 265 - 272.
[Abstract] [Full Text]


HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1988 by the American College of Cardiology Foundation.